Table 3.
Relationship between localization of claudin‐1 expression and clinicopathological features of claudin‐1‐high patients
No. of patients | |||
---|---|---|---|
Intracellular | Membrane | ||
Differentiation | |||
Well | 9 | 15 | |
Moderate | 8 | 6 | |
Poor | 4 | 0 | P = .06 |
YK classification | |||
YK‐1 | 0 | 0 | |
YK‐2 | 0 | 3 | |
YK‐3 | 12 | 14 | |
YK‐4c | 6 | 4 | |
YK‐4d | 3 | 0 | P = .10 |
Local recurrence | |||
Positive | 4 | 1 | |
Negative | 17 | 20 | P = .34 |
Cervical lymph node metastasis | |||
Positive | 15 | 2 | |
Negative | 6 | 19 | P = .0000929 |
Distant organ metastasis | |||
Positive | 2 | 0 | |
Negative | 19 | 21 | P = .48 |